LAKE FOREST, Ill., Aug. 12 /PRNewswire-FirstCall/ -- Hospira, Inc.
(NYSE: HSP), a leading global specialty pharmaceutical and
medication delivery company, today announced that it will host a
biosimilars investor education forum on Thursday, Aug. 19, 2010. The event, which will
feature presentations by various members of the company's R&D
and Specialty Pharmaceuticals organizations, will highlight
biosimilars in general, as opposed to focusing on the company's
biosimilar program.
A streaming audio webcast of the event, which will include the
slides presented during the event, will be available on the
Investor Relations section of Hospira's Web site at
www.hospirainvestor.com. The presentations are expected to begin at
approximately 8 a.m. Central time and
conclude at approximately 12 p.m.
They will be available to all interested parties through a live
audio webcast accessible via the investor relations section of
Hospira's Web site at www.hospirainvestor.com. Listeners should log
on approximately 10 minutes in advance to ensure proper setup for
accessing the audio webcast. A replay of the webcast will be
available on the Hospira Web site approximately 24 hours after the
conclusion of the event.
About Hospira
Hospira, Inc. is a global specialty pharmaceutical and
medication delivery company dedicated to Advancing Wellness™. As
the world leader in specialty generic injectable pharmaceuticals,
Hospira offers one of the broadest portfolios of generic acute-care
and oncology injectables, as well as integrated infusion therapy
and medication management solutions. Through its products, Hospira
helps improve the safety, cost and productivity of patient care.
The company is headquartered in Lake
Forest, Ill., and has approximately 13,500 employees. Learn
more at www.hospira.com.
SOURCE Hospira, Inc.
Copyright . 12 PR Newswire